anubhai
Back OfficeNippon India Pharma Fund (Bonus)
Summary
| Fund Name | Nippon India Mutual Fund |
| Scheme Name | Nippon India Pharma Fund (Bonus) |
| AMC | Nippon India Mutual Fund |
| Type | Open |
| Category | Equity - Pharma |
| Launch Date | 10-May-2004 |
| Fund Manager | Sailesh Raj Bhan |
| Net Assets(Rs. cr) | 8,306.35 |
NAV Graph
| One Month | Three Month | Six Month | One Year | Three Year | Five Year |
Latest Payouts
| Dividends | Bonus |
|---|
Performance
| 1 Week (%) | 1 Month (%) | 3 Month (%) | 6 Month (%) | 1 Year (%) | 3 Year (%) | 5 Year (%) | Since INC (%) | |
|---|---|---|---|---|---|---|---|---|
| Scheme Return | 0.13 | 1.75 | 1.12 | -0.34 | 10.36 | 24.29 | 15.51 | 19.83 |
| Category Avg | -1.07 | 1.25 | -0.95 | -2.40 | 8.80 | 24.56 | 15.87 | 12.89 |
| Category Best | -0.28 | 4.02 | 2.79 | 2.01 | 15.83 | 28.28 | 18.31 | 27.05 |
| Category Worst | -2.80 | -1.49 | -6.64 | -5.84 | 0.30 | 20.73 | 12.00 | -5.81 |
Asset Allocation
Holdings
| Company Name | % Hold |
|---|---|
| Sun Pharma.Inds. | 13.08 |
| Lupin | 7.99 |
| Divi's Lab. | 6.56 |
| Dr Reddy's Labs | 5.81 |
| Cipla | 5.67 |
| Apollo Hospitals | 5.17 |
| Medplus Health | 3.70 |
| Max Healthcare | 3.49 |
| Vijaya Diagnost. | 3.49 |
| Ajanta Pharma | 3.41 |
| Sai Life | 3.07 |
| Mankind Pharma | 3.06 |
| Glaxosmi. Pharma | 2.83 |
| Ipca Labs. | 2.51 |
| Aurobindo Pharma | 2.50 |
| Abbott India | 2.37 |
| Alkem Lab | 2.20 |
| Thyrocare Tech. | 2.08 |
| Dr Lal Pathlabs | 2.05 |
| J B Chemicals & | 1.98 |
| Pfizer | 1.94 |
| Narayana Hrudaya | 1.82 |
| Gland Pharma | 1.76 |
| Emcure Pharma | 1.31 |
| Suraksha Diagno. | 1.27 |
| Fortis Health. | 1.25 |
| Sanofi Consumer | 1.15 |
| Sanofi India | 1.10 |
| Biocon | 1.04 |
| Syngene Intl. | 0.96 |
| Anthem Bioscienc | 0.89 |
| Akums Drugs | 0.89 |
| Astrazeneca Phar | 0.67 |
| Indoco Remedies | 0.45 |
| Concord Biotech | 0.16 |
| TREPS | 0.34 |
| Net CA & Others | -0.02 |
| C C I | 0.00 |
